Cycloserine-induced Stevens-Johnson syndrome in an AIDS patient with multidrug-resistant tuberculosis

International Journal of Tuberculosis and Lung Disease

Volumn 1, Issue 2, 1997, Pages 187-190

  Akula, S K ^a,b   Aruna, A S ^b,c   Johnson, J E ^a,b   Anderson, D S ^b  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c XAVIER UNIVERSITY OF LOUISIANA   (United States)

Author keywords

AIDS; Cycloserine; MDR TB; Stevens johnson syndrome

Indexed keywords

CYCLOSERINE; TUBERCULOSTATIC AGENT;

ADULT; AIDS RELATED COMPLEX; ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; DRUG COMBINATION; FATALITY; HUMAN; MALE; RASH; STEVENS JOHNSON SYNDROME; TUBERCULOSIS;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIBIOTICS, ANTITUBERCULAR; CYCLOSERINE; DRUG THERAPY, COMBINATION; EXANTHEMA; FATAL OUTCOME; HUMANS; MALE; STEVENS-JOHNSON SYNDROME; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 0031107967     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Conte J I, Jr., Barriere S L. Manual of antibiotics and infectious diseases. 6th ed. Lee & Febiger, Philadelphia, 1988.
2. Eh Lilly Pharmaceutical Corporation. Cycloserine product information. Indianapolis, 1990.
3. Stevens A M, Johnson F C. A new eruptive fever associated with stomatitis and ophthalmia: report of two cases in children. Am J Dis Child 1922; 24: 526-533.
4. Huff J C, Weston W L, Tonnesen M G. Erythema multiforme: a critical review of characteristics, diagnosis criteria, and causes. J Am Acad Dermatol 1983; 8: 763-775.
5. Bastuji-Garin S, Rzany B, Stern R S, Shear N H, Naldi L, Roujeau J C. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 1993; 129: 92-96.
6. Anderson J A. Allergic reactions to drugs and biological agents. JAMA 1992; 268: 2845-2857.
7. Roujeau J C, Kelly J P, Naldi L, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995; 333: 1600-1607.
8. Schopf E, Stubmer A, Rzany B, Victor N, Zentgraf R, Kapp J F. Toxic epidermal necrolysts and Stevens-Johnson syndrome: an epidemiologic study from West Germany. Arch Dermatol 1991; 127: 839-842.
9. Chan H L, Stern R S, Arndt K A, et al. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: a population-based study with particular reference to reactions caused by drugs among out-patients. Arch Dermatol 1990; 126: 43-47.
10. Roujeau J C, Stern R S. Severe cutaneous reactions to drugs. N Engl J Med 1994; 331: 1272-1285.
11. Israel D S, Plaisance K I. Neutropenia in patients infected with human immunodeficiency virus. Clin Pharm 1991; 10: 268-279.
12. Coopman S A, Johnson R A, Platt R, Stern R S. Cutaneous disease and drug reactions in HIV infection. N Engl J Med 1993; 328: 1670-1674.
13. Porteous D M, Berger T G. Severe cutaneous drug reactions (Stevens-Johnson syndrome and toxic epidermal necrolysis) in human immunodeficiency virus infection. Arch Dermatol 1992; 127: 740-741.
14. Rzany B, Mockenhaupt M, Stocker U, Hamouda O, Schopf E. Incidence of Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with acquired immunodeficiency syndrome in Germany. Arch Dermatol 1993; 129: 1059.
15. Zhang Y, Young D. Molecular genetics of drug resistance in Mycobacterium tuberculosis. J Antimicrob Chemother 1994; 34: 313-319.